Restructuring of the Quality Improvement Organization Program and the Impact to Medicare Advantage Organizations and Prescription Drug Plans
Guidance for Medicare Advantage Organizations (MAOs) and Prescription Drug Plans (PDPs) that CMS is restructuring the Quality Improvement Organization (QIO) program to improve both patient care and health outcomes, and save taxpayer resources. The overall restructuring of the QIO program will allow for the creation of Beneficiary and Family-Centered Care Quality Improvement Organizations (BFCC-QIOs) contractors to support the program in five service areas.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: July 24, 2014
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.